Send mail to Author

HCVerso3 : an open-label, phase IIb study of Faldaprevir and Deleobuvir with Ribavirin in hepatitis C virus genotype-1b-infected patients with cirrhosis and moderate hepatic impairment (Article)

Please indicate your contact information and select, which author you want to contact.



 
 _    _     ______    _  _    _    _     _____     ______  
| || | ||  /_   _//  | \| || | || | ||  /  ___||  /_   _// 
| || | ||   -| ||-   |  ' || | || | || | // __     -| ||-  
| \\_/ ||   _| ||_   | .  || | \\_/ || | \\_\ ||   _| ||_  
 \____//   /_____//  |_|\_||  \____//   \____//   /_____// 
  `---`    `-----`   `-` -`    `---`     `---`    `-----`
 


Back to frontdoor view

OPUS4 Logo